Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

UCLA, UCSF obtain FDA approval for PSMA PET imaging in men with prostate cancer

UCLA, UCSF obtain FDA approval for PSMA PET imaging in men with prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Experimental drug can reverse age-related memory decline in mice

Experimental drug can reverse age-related memory decline in mice

Cost of prostate cancer treatment can be a major source of stress for men, their families

Cost of prostate cancer treatment can be a major source of stress for men, their families

Researchers find substantial regional variation in use of genomic testing for prostate cancer

Researchers find substantial regional variation in use of genomic testing for prostate cancer

World’s largest proteomics centre accelerates biomarker discoveries to improve people’s lives

World’s largest proteomics centre accelerates biomarker discoveries to improve people’s lives

Medical mistrust can make African Americans to regret their choice of treatment for prostate cancer

Medical mistrust can make African Americans to regret their choice of treatment for prostate cancer

Study assesses impact of social needs on African American cancer survivors

Study assesses impact of social needs on African American cancer survivors

New findings could pave the way for more effective, safer and cheaper gene therapy

New findings could pave the way for more effective, safer and cheaper gene therapy

Study identifies enzyme vital to the metastatic growth of prostate cancer cells

Study identifies enzyme vital to the metastatic growth of prostate cancer cells

CRYM protein counteracts the growth of prostate tumors

CRYM protein counteracts the growth of prostate tumors

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Researchers explain why COVID-19 infects older people and spares younger children

Researchers explain why COVID-19 infects older people and spares younger children

Men and women may require different brain tumor therapy, study finds

Men and women may require different brain tumor therapy, study finds

Grants give military veterans better access to cancer clinical trials

Grants give military veterans better access to cancer clinical trials

Gene signature may help develop new therapies against advanced prostate cancer

Gene signature may help develop new therapies against advanced prostate cancer

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Unrelated mutations can lead to false-positive results in men with advanced prostate cancer

Unrelated mutations can lead to false-positive results in men with advanced prostate cancer

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

Researchers identify a novel vulnerability in advanced prostate cancer

Researchers identify a novel vulnerability in advanced prostate cancer